Women’s ProMulti Effectiveness Research Abstract

Real-World Effectiveness, Onset, and Advocacy of Women’s ProMulti: User-Reported Outcomes from a Cross-Sectional Feedback Survey

June 2026

Key Findings

1. 92.3% of users who gave a definitive rating found Women’s ProMulti effective, with 35.9% rating it extremely effective and not a single respondent rating it ‘not at all effective’.
   
2. 89.7% of users who had tried other multivitamins or daily greens judged Women’s ProMulti better than their previous product, 53.8% ‘a lot better’, and none rated it worse.
   
3. Onset of benefit was rapid: 50.0% of responders noticed results within four weeks and 84.2% within eight weeks.
   
4. Advocacy was strong: a mean recommendation score of 8.2 out of 10, 81.6% scoring 7 or above, and a Net Promoter Score of +35.
   
5. ‘Too early to say’ responses were almost entirely confined to short-term users: 10 of 11 had taken the product for under two months, indicating that the headline effectiveness figure is conservative and likely to rise with continued use.

Background and Methods

Women’s ProMulti is a comprehensive multivitamin and probiotic formulation developed by DR.VEGAN^® to support women’s overall health, gut health, and nutrient sufficiency. This abstract reports real-world, user-reported outcomes from a cross-sectional feedback survey of 50 verified Women’s ProMulti users (June 2026). Respondents reported their age, duration and consistency of use, goals for taking the product, overall effectiveness (four-point scale plus a ‘too early to say’ option), specific benefits experienced, time to first results, comparison with previously used multivitamins or greens, and likelihood to recommend (1–10). Effectiveness and comparison percentages are reported among respondents who provided a definitive answer, excluding ‘too early to say’ and ‘haven’t tried others’ where applicable. Individual-level data were analysed for all 50 responses.

Results

Cohort profile

The cohort skewed toward midlife women: 64.0% were aged 45–64 and 80.0% were aged 45 or over, placing the majority within the peri- and postmenopausal window. Adherence was high - 84.0% took the product daily and the remaining 16.0% on most days - lending confidence that reported outcomes reflect consistent use. Duration of use was weighted toward newer users: 62.0% had taken the product for under two months, with 38.0% at two months or longer. The dominant reasons for starting were overall wellbeing (80.0%), ensuring adequate essential nutrients (50.0%), metabolism and gut health (38.0%), and hormone regulation (34.0%).

Overall effectiveness

Among the 39 respondents who gave a definitive effectiveness rating, 92.3% rated Women’s ProMulti effective - 35.9% extremely effective and 56.4% somewhat effective. Only 7.7% (n=3) rated it ‘not so effective’ and none rated it ‘not at all effective’, giving a combined negative rate of 7.7%. See Figure 1.

Goals versus benefits realised

The most commonly realised benefit was better overall wellbeing (50.0% of all respondents), aligning with the leading reason for use. Notably, mood (reported as a benefit by 28.0% against a 20.0% starting goal) and sleep (16.0% against 14.0%) were experienced as benefits by more users than had set out to address them, suggesting unanticipated secondary gains. Figure 2 maps starting goals against benefits realised across domains.

Onset, comparison and advocacy

Onset of perceptible benefit was rapid, with half of responders noticing results within four weeks and 84.2% within eight. Against prior products, 89.7% of those who had tried other multivitamins or greens rated Women’s ProMulti better, with none rating it worse. Advocacy metrics were strong, with a mean recommendation score of 8.2 out of 10 and a Net Promoter Score of +35. See Figure 3.

Conclusions

In this real-world feedback survey, Women’s ProMulti demonstrated a high user-reported effectiveness rate (92.3% among rated users), rapid onset of benefit, strong preference over previously used multivitamins and greens, and robust advocacy (NPS +35). The concentration of ‘too early to say’ responses among users of under two months suggests the headline effectiveness figure is conservative and would likely strengthen with longer follow-up, consistent with the duration-dependent benefit observed in other DR.VEGAN^® supplement evaluations. The emergence of mood and sleep benefits beyond users’ original goals points to broader-spectrum support than anticipated at initiation. The principal limitations are the modest sample (n=50), the absence of a control group, and the short median duration of use; prospective evaluation with a larger cohort and defined follow-up intervals would allow these promising real-world signals to be confirmed and the duration–response relationship to be characterised formally.

Keywords: Women’s ProMulti, multivitamin, daily greens, women’s health, user-reported outcomes, real-world effectiveness, net promoter score, nutrient sufficiency, menopause, overall wellbeing

Survey date: June 2026  |  Respondents: N = 50  |  Rated users (excl. ‘too early’): N = 39   

---

Media enquiries: Please contact [email protected]